LRRK2-associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization

Chahine, L. M., Lafontant, D.-E., Choi, S. H., Iwaki, H., Blauwendraat, C., Singleton, A. B., Brumm, M. C., Alcalay, R. N., Merchant, K., Nudelman, K. N. H., Dagher, A., Vo, A., Tao, Q., Venuto, C. S., Kieburtz, K., Poston, K. L., Bressman, S., Gonzalez-Latapi, P., Avants, B., … Tolosa, E. (2025). LRRK2-associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization. Brain Communications, 7(2). https://doi.org/10.1093/braincomms/fcaf103
Authors:
Lana M Chahine
David-Erick Lafontant
Seung Ho Choi
Hirotaka Iwaki
Cornelis Blauwendraat
Andrew B Singleton
Michael C Brumm
Roy N Alcalay
Kalpana Merchant
Kelly Nicole Holohan Nudelman
Alain Dagher
Andrew Vo
Qin Tao
Charles S Venuto
Karl Kieburtz
Kathleen L Poston
Susan Bressman
Paulina Gonzalez-Latapi
Brian Avants
Christopher Coffey
Danna Jennings
Eduardo Tolosa
Andrew Siderowf
Ken Marek
Tatyana Simuni
Affiliated Authors:
Roy N Alcalay
Author Keywords:
alpha-synuclein
parkinson's disease
lrrk2 gene
parkinson’s disease
Publication Type:
Article
Unique ID:
10.1093/braincomms/fcaf103
PMID:
Publication Date:
Data Source:
PubMed

Record Created: